End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.63 CAD | -6.07% |
|
+17.41% | +76.51% |
Jun. 26 | Cybin Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Jun. 11 | Cybin Inc. Appoints Atul R. Mahableshwarkar as Senior Vice President, Clinical Development | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eric So
FOU | Founder | 49 | 16-10-12 |
Paul Glavine
FOU | Founder | 35 | 16-10-12 |
Douglas Drysdale
CEO | Chief Executive Officer | 54 | 20-07-31 |
Greg Cavers
DFI | Director of Finance/CFO | 54 | 20-11-04 |
Chief Tech/Sci/R&D Officer | - | 22-03-31 | |
Alex Nivorozhkin
CTO | Chief Tech/Sci/R&D Officer | 64 | 20-11-30 |
Ryan Richardson
CTO | Chief Tech/Sci/R&D Officer | - | - |
Liz Galic
COO | Chief Operating Officer | - | - |
Amir Inamdar
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Aaron Bartlone
COO | Chief Operating Officer | - | 20-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eric So
FOU | Founder | 49 | 16-10-12 |
Mark Lawson
BRD | Director/Board Member | 52 | 20-11-04 |
Grant Froese
BRD | Director/Board Member | 62 | 20-11-04 |
Director/Board Member | 68 | 21-08-15 | |
George Tziras
BRD | Director/Board Member | 43 | 23-10-22 |
Eric Hoskins
BRD | Director/Board Member | 63 | 20-11-04 |
Paul Glavine
FOU | Founder | 35 | 16-10-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 743,885,052 | 691,909,806 ( 93.01 %) | 0 | 93.01 % |
Company contact information
![address Cybin Inc.(CLXP.F)](https://cdn.zonebourse.com/static/address/119074775.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- CYBN Stock
- CLXP.F Stock
- Company Cybin Inc.